Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-001828
Filing Date
2025-03-17
Accepted
2025-03-17 16:15:22
Documents
70
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q zeoscientifix_10q.htm   iXBRL 10-Q 515657
2 EXHIBIT 31.1 zeoscientifix_ex31-1.htm EX-31.1 12712
3 EXHIBIT 32.1 zeoscientifix_ex32-1.htm EX-32.1 4703
  Complete submission text file 0001829126-25-001828.txt   3859693

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE zeox-20250131.xsd EX-101.SCH 41399
5 XBRL CALCULATION FILE zeox-20250131_cal.xml EX-101.CAL 47627
6 XBRL DEFINITION FILE zeox-20250131_def.xml EX-101.DEF 149328
7 XBRL LABEL FILE zeox-20250131_lab.xml EX-101.LAB 309302
8 XBRL PRESENTATION FILE zeox-20250131_pre.xml EX-101.PRE 277847
72 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_10q_htm.xml XML 423497
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 25744610
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)